My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1451

    1.

    Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.

    Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP.

    Breast Cancer Res. 2009;11(1):R14. Epub 2009 Feb 27.PMID: 19250546 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay.

    Rauch T, Wang Z, Zhang X, Zhong X, Wu X, Lau SK, Kernstine KH, Riggs AD, Pfeifer GP.

    Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5527-32. Epub 2007 Mar 16.PMID: 17369352 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.

    Kang JH, Kim SJ, Noh DY, Park IA, Choe KJ, Yoo OJ, Kang HS.

    Lab Invest. 2001 Apr;81(4):573-9.PMID: 11304577 [PubMed - indexed for MEDLINE]Related articles

    4.

    DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells.

    Rivenbark AG, Jones WD, Risher JD, Coleman WB.

    Epigenetics. 2006 Jan-Mar;1(1):32-44. Epub 2005 Nov 18.PMID: 17998816 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.

    Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH.

    Cancer Res. 2003 Oct 1;63(19):6178-86.PMID: 14559801 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.

    Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A, Hidalgo M, Goggins M.

    Cancer Biol Ther. 2008 Jul;7(7):1146-56. Epub 2008 Apr 29.PMID: 18535405 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.

    Versmold B, Felsberg J, Mikeska T, Ehrentraut D, Köhler J, Hampl JA, Röhn G, Niederacher D, Betz B, Hellmich M, Pietsch T, Schmutzler RK, Waha A.

    Int J Cancer. 2007 Aug 1;121(3):547-54.PMID: 17415710 [PubMed - indexed for MEDLINE]Related articles

    8.

    Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

    Hoque MO, Prencipe M, Poeta ML, Barbano R, Valori VM, Copetti M, Gallo AP, Brait M, Maiello E, Apicella A, Rossiello R, Zito F, Stefania T, Paradiso A, Carella M, Dallapiccola B, Murgo R, Carosi I, Bisceglia M, Fazio VM, Sidransky D, Parrella P.

    Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2694-700. Epub 2009 Sep 29.PMID: 19789364 [PubMed - indexed for MEDLINE]Related articles

    9.

    A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.

    Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD.

    PLoS Med. 2006 Dec;3(12):e486.PMID: 17194187 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.

    Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD.

    World J Gastroenterol. 2004 Dec 1;10(23):3441-54.PMID: 15526363 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.

    Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP.

    PLoS Genet. 2007 Oct;3(10):2023-36. Epub 2007 Sep 10.PMID: 17967063 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation.

    McCabe MT, Lee EK, Vertino PM.

    Cancer Res. 2009 Jan 1;69(1):282-91.PMID: 19118013 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.

    Nass SJ, Herman JG, Gabrielson E, Iversen PW, Parl FF, Davidson NE, Graff JR.

    Cancer Res. 2000 Aug 15;60(16):4346-8.PMID: 10969774 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

    Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.

    Clin Cancer Res. 2003 Dec 15;9(17):6389-94.PMID: 14695139 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.

    Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lübbert M, Zhou JH, Benedict WF, Jones PA.

    J Natl Cancer Inst. 2001 Oct 3;93(19):1465-72.PMID: 11584062 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer.

    Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY, Koeffler HP.

    Breast Cancer Res Treat. 2007 Oct;105(2):139-55. Epub 2007 Feb 13.PMID: 17295047 [PubMed - indexed for MEDLINE]Related articles

    17.

    Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.

    Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, Chambers AF.

    Breast Cancer Res. 2008;10(4):R62. Epub 2008 Jul 18.PMID: 18638373 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Methylation profiling of CpG islands in human breast cancer cells.

    Huang TH, Perry MR, Laux DE.

    Hum Mol Genet. 1999 Mar;8(3):459-70.PMID: 9949205 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.

    Yu J, Zhang H, Gu J, Lin S, Li J, Lu W, Wang Y, Zhu J.

    BMC Cancer. 2004 Sep 14;4:65.PMID: 15367334 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.

    Okuda H, Toyota M, Ishida W, Furihata M, Tsuchiya M, Kamada M, Tokino T, Shuin T.

    Oncogene. 2006 Mar 16;25(12):1733-42.PMID: 16278676 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk